Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
Department of Psychiatry, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
PLoS One. 2021 Dec 3;16(12):e0260929. doi: 10.1371/journal.pone.0260929. eCollection 2021.
INTRODUCTION: Previous studies have revealed that the COVID-19 pandemic can cause psychological distress such as depression and anxiety. Patients with chronic kidney disease (CKD) might be more vulnerable to psychological distress due to the COVID-19 pandemic. Its impact could be different according to dialysis modality. The aim of this study was to investigate COVID-19-related psychological stress experienced by end-stage kidney disease (ESKD) patients and identify differences in concerns about COVID-19 between hemodialysis (HD) and peritoneal dialysis (PD) patients. METHODS: This cross-sectional study included 148 dialysis patients at Soonchunhyang University Cheonan Hospital from August 2020 to September 2020. These patients responded to a questionnaire covering mental health status and COVID-19 related concerns. Symptoms of depression, anxiety, stress, and insomnia were measured using a 9-item Patient Health Questionnaire (PHQ-9), a 7-item Generalized Anxiety Disorder (GAD-7) scale, a 22-item Impact of Event Scale-Revised (IES-R), and a 7-item Insomnia severity Index (ISI), respectively. Outcomes of HD and PD patients were compared by propensity score matching analysis. RESULTS: Dialysis patients reported psychological distress including symptoms of depression, anxiety, stress, and insomnia. HD patients showed higher scores for depression (p = 0.018), anxiety(p = 0.005), stress(p<0.001), and insomnia(p = 0.006) than the PD patients. After propensity score matching, HD was associated with depression(p = 0.0131), anxiety(p = 0.0143), and stress(p = 0.000415). CONCLUSION: Dialysis patients showed psychological distress during the COVID-19 pandemic period, with HD patients having more severe symptoms than PD patients.
简介:先前的研究表明,COVID-19 大流行可导致抑郁和焦虑等心理困扰。由于 COVID-19 大流行,慢性肾脏病(CKD)患者可能更容易受到心理困扰。其影响可能因透析方式而异。本研究旨在调查终末期肾病(ESKD)患者在 COVID-19 大流行期间经历的与 COVID-19 相关的心理压力,并确定血液透析(HD)和腹膜透析(PD)患者对 COVID-19 的担忧的差异。
方法:本横断面研究纳入了 2020 年 8 月至 2020 年 9 月期间在顺天乡大学全州医院的 148 名透析患者。这些患者通过问卷回答了心理健康状况和与 COVID-19 相关的担忧。使用 9 项患者健康问卷(PHQ-9)、7 项广泛性焦虑症(GAD-7)量表、22 项修订后的事件影响量表(IES-R)和 7 项失眠严重指数(ISI)分别测量抑郁、焦虑、压力和失眠的症状。通过倾向评分匹配分析比较 HD 和 PD 患者的结果。
结果:透析患者报告了包括抑郁、焦虑、压力和失眠在内的心理困扰。HD 患者的抑郁(p=0.018)、焦虑(p=0.005)、压力(p<0.001)和失眠(p=0.006)得分均高于 PD 患者。经过倾向评分匹配后,HD 与抑郁(p=0.0131)、焦虑(p=0.0143)和压力(p=0.000415)相关。
结论:在 COVID-19 大流行期间,透析患者表现出心理困扰,HD 患者的症状比 PD 患者更严重。
Am J Med Sci. 2017-12-1
Ther Apher Dial. 2020-8
Kidney Res Clin Pract. 2024-1
Healthcare (Basel). 2023-9-14
Int Urol Nephrol. 2024-2
Eur J Public Health. 2021-7-13
J Nephrol. 2021-4
J Family Med Prim Care. 2020-8-25
Diabetes Metab Syndr. 2020
J Am Soc Nephrol. 2020-5-28